TENX - TENAX THERAPEUTICS, INC.
14.51
3.490 24.052%
Share volume: 2,124,757
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$11.02
3.49
0.32%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-13-2024 | 03-25-2025 | 05-14-2025 | 08-13-2025 | 11-12-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 3.908 M | 3.672 M | 4.619 M | 0.000 | 11.338 M | 11.792 M | 16.806 M | |
| Selling general and admin | 1.233 M | 1.344 M | 1.507 M | 0.000 | 5.655 M | 5.671 M | 6.478 M | |
| Research and development | 2.676 M | 2.328 M | 3.112 M | 0.000 | 5.683 M | 6.121 M | 10.328 M | |
| Total expenses | 3.908 M | 3.672 M | 4.619 M | 0.000 | 11.338 M | 11.792 M | 16.806 M | |
| -6.05% | 25.79% | -100.00% | 4.00% | 42.52% | ||||
| Operating income | -3.908 M | 3.672 M | 4.619 M | 0.000 | -11.338 M | -11.792 M | -16.806 M | |
| Ebit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Pretax income | -3.916 M | -3.577 M | -4.625 M | 0.000 | -10.408 M | -10.847 M | -15.804 M | |
| -8.66% | 29.30% | -100.00% | 4.22% | 45.70% | ||||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -3.799 M | 3.576 M | 3.960 M | 0.000 | -10.408 M | -10.847 M | -15.804 M | |
| 194.13% | 10.76% | -100.00% | -4.22% | -45.70% |